? """"""""Metabolic Syndrome, Inflammation, and Vascular Remodeling"""""""" is the central theme of this SCCOR. Inflammation is increasingly accepted as a major contributor to the pathogenesis of coronary heart disease (CHD) and type 2 diabetes. Insulin resistance and the metabolic syndrome appear to be at the root of the pathogenic process. In this SCCOR grant we have united important new discoveries in diverse areas of research to determine whether primary targeting of inflammation as a therapeutic goal provides a new route to treat CHD. We will target inflammation via lifestyle intervention, indirectly using PPARa agonists, and directly by inhibiting the NF-KB pathway, the master switch of inflammation. We will combine these novel series of interventions with a newly developing, state-of-the-art, minimally invasive imaging technique, multidetector computed tomographic angiography (MDCTA) that examines dynamic processes in the coronary circulation, including the development and regression of soft and hard plaques.
Specific Aims i nclude: Project by Shoelson: To determine how obesity- and Western diet-induced inflammation influences CHD in animal models. We have discovered that obesity activates a subacute inflammatory process in fat and liver via NF-KB, which leads to the production of cytokines and causes systemic insulin resistance. We have hypothesized that the obesity-driven production of these cytokines promotes CHD and will test this in relevant rodent models. In a series of three clinical projects we will use different interventions to target subacute inflammation in patients with established CHD and assess the effect of the interventions on regression of soft plaque assessed by MDCTA. Project by Welty: Since Western diet and obesity activate the NF-KB cascade, we hypothesize that weight loss achieved through dietary and exercise intervention will suppress the subacute inflammatory process to promote vascular remodeling and regression of soft plaque, and in Project by Goldfarb: We will directly target the inflammatory signaling

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL083813-03
Application #
7433253
Study Section
Special Emphasis Panel (ZHL1-CSR-A (F1))
Program Officer
Mcdonald, Cheryl
Project Start
2006-05-01
Project End
2013-04-30
Budget Start
2008-05-01
Budget End
2011-04-30
Support Year
3
Fiscal Year
2008
Total Cost
$2,643,714
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Ikezaki, Hiroaki; Ai, Masumi; Schaefer, Ernst J et al. (2017) Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study. J Clin Lipidol 11:348-356
Thongtang, Nuntakorn; Diffenderfer, Margaret R; Ooi, Esther M M et al. (2017) Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin. J Lipid Res 58:1315-1324
Salastekar, Ninad; Desai, Tanvi; Hauser, Thomas et al. (2017) Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trial. Diabetes Obes Metab 19:1458-1462
Goldfine, Allison B; Shoelson, Steven E (2017) Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest 127:83-93
Elajami, Tarec K; Colas, Romain A; Dalli, Jesmond et al. (2016) Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J 30:2792-801
Ikezaki, Hiroaki; Ai, Masumi; Schaefer, Ernst J et al. (2016) Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study. Sci Rep 6:36725
Welty, Francine K; Alfaddagh, Abdulhamied; Elajami, Tarec K (2016) Targeting inflammation in metabolic syndrome. Transl Res 167:257-80
Asztalos, Ivor B; Gleason, Joi A; Sever, Sakine et al. (2016) Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial. Metabolism 65:1636-1645
Diffenderfer, Margaret R; Lamon-Fava, Stefania; Marcovina, Santica M et al. (2016) Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism 65:381-90
Hegele, Robert A; Gidding, Samuel S; Ginsberg, Henry N et al. (2015) Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol 35:2269-80

Showing the most recent 10 out of 67 publications